FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental NDA for Lotensin (benazepril hydrochloride) filed by Validus Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Lotensin (benazepril hydrochloride)

Snippet

SUPPL AP for LOTENSIN (BENAZEPRIL HYDROCHLORIDE)